Video | July 16, 2021

The Decision To Follow A Mentor From Vanderbilt To NYU

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Rahul Aras, Ph.D., CEO of Iterion Therapeutics, a clinical stage company developing cancer therapeutics, discusses the decision to follow his Ph.D. mentor from Vanderbilt to NYU, and how it led to his first academic job, and later working with a Nobel Laureat.